Social phobia: Epidemiology and cost of illness

Joshua D. Lipsitz, Franklin R. Schneier

Research output: Contribution to journalReview articlepeer-review

70 Scopus citations

Abstract

Social phobia is a prevalent and debilitating psychiatric disorder. It entails significant economic costs in the form of educational underachievement, increased financial dependency, decreased work productivity, social impairment and poorer quality of life. It is associated with increased prevalence of other psychiatric disorders including depression and alcohol dependence. Its onset is early and typically precedes onset of comorbid disorders. Despite its debilitating effects, social phobia is often unrecognised and is undertreated. The availability of efficacious pharmacological and psychotherapeutic treatments for social phobia makes it imperative to carefully consider the impact of this disorder and to consider the cost effectiveness of available treatments.

Original languageEnglish
Pages (from-to)23-32
Number of pages10
JournalPharmacoEconomics
Volume18
Issue number1
DOIs
StatePublished - 1 Jan 2000
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Social phobia: Epidemiology and cost of illness'. Together they form a unique fingerprint.

Cite this